Here, we report the draft genome sequence of high-temperature-adapted Protochlamydia sp. strain HS-T3, an environmental chlamydia. This bacterium is an amoebal endosymbiont, found in Acanthamoeba isolated from a hot spring in Japan. Strain HS-T3 readily grew in mammalian cells at 37°C, a characteristic not previously reported for environmental chlamydiae.
hlamydiae is a bacterial phylum and class comprising obligate intracellular bacteria. Two distinct lineages exist, pathogenic and environmental chlamydiae, and this divergence likely occurred 0.7 to 1.4 billion years ago (1) . Pathogenic chlamydiae, including Chlamydia trachomatis and Chlamydia pneumoniae, are well-known human pathogens causing ocular infection resulting in trachoma (preventable blindness) (2), sexually transmitted diseases with an estimated five million new cases annually worldwide (3), and community-acquired pneumonia (4). However, evidence showing an association between environmental chlamydiae and pathogenesis is limited. Pathogenic chlamydiae have successfully adapted to growth in mammalian cells, including human cells (which provide a stable environment with minimal temperature changes) through genome reduction, with an average genomic size of around 1.0 Mb (5). In contrast, environmental chlamydiae have co-evolved with their invertebrate hosts as endosymbionts of lower eukaryotes, free-living amoebae such as Acanthamoeba, adapting to a less hospitable environment with a relatively low temperature, likely without genome reduction (1, 6) . Most environmental chlamydiae therefore have not successfully been cultured in mammalian cells at the general culture temperature of 37°C (7, 8) . However, we recently identified an environmental chlamydia, high-temperature-adapted Protochlamydia sp. strain HS-T3, which can readily grow in human immortal HEp-2 epithelial cells under normal culture conditions. This strain was identified in Acanthamoeba isolated from a hot spring in Kanagawa prefecture, Japan (9) .
The draft genome of Protochlamydia HS-T3 was obtained using an Illumina HiSeq 2000 sequencer (Illumina, San Diego, CA, USA), with sequencing runs for paired-end sequences. The bacterial DNA libraries were prepared using a TruSeq DNA sample kit (Illumina). The genome was assembled into 34 contigs, ranging in size from 189 to 363,061 bp, using de novo sequence assembler software (Velvet, EMBL-EBI) (10) . Gene prediction was performed with Rapid Annotation using Subsystem Technology (RAST) (http://rast.nmpdr.org/) (11), and functional annotation was performed using the Kyoto Encyclopedia of Genes and Genomes (KEGG) (http://www.genome.jp/kegg/) (12) . The sequencing runs and read assembly of the libraries were carried out by Hokkaido System Science (Sapporo, Japan).
The draft genome sequence of Protochlamydia sp. HS-T3 was 2,308,589 bp (2.3 Mb) with a GϩC content of 38.74% and 950-fold genome coverage. The genome sequence contained 2,259 coding sequences, 40 tRNAs, and 2 ribosomal RNAs. Neighbor analysis using RAST revealed that the closest neighbor of Protochlamydia HS-T3 was Protochlamydia amoebophila UWE25 (NC_005861.1) (6), which is unable to grow in cells derived from higher forms of life, such as insects (13) . Similarly to Protochlamydia UWE25, Protochlamydia HS-T3 was found by KEGG analysis to possess central carbon metabolic pathways (e.g., the Embden-Meyerhof pathway, tricarboxylic acid cycle, pentose phosphate pathway, Entner-Doudoroff pathway, and fatty acid biosynthesis) and type III general secretion gene clusters but lacked the genes encoding the type IV secretion system. In addition, 1,139 hypothetical proteins and 8 unknown proteins were identified.
Nucleotide sequence accession numbers. The draft genome sequence of Protochlamydia HS-T3 has been deposited at DDBJ/ EMBL/GenBank under the accession numbers BBPT01000001 through BBPT01000034 (34 entries). The version described in this paper is the first version.
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